Latest News
-
CAMBRIDGE, Mass. – Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that the U.S. Food and Drug Administration (FDA) has approved AYVAKIT™ (avapritinib) for the treatment of adult patients with advanced systemic mastocytosis (Advanced SM), including aggressive SM (ASM), SM with an associated hematological neoplasm (SM-AHN) and mast cell leukemia (MCL).... -
FOSTER CITY, Calif. – Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced the publication of data from the IMbark Phase 2 clinical trial in the Journal of Clinical Oncology in a paper entitled, “Randomized, Single-Blind, Multicenter Phase II Study of Two Doses of Imetelstat in Relapsed or...
-
CAMBRIDGE, Mass. – Biogen Inc. (Nasdaq: BIIB) announced that the first patient has been dosed in the global clinical study, TOPAZ-1. The Phase 3 study will evaluate the clinical efficacy and assess the safety of BIIB059, a first in-class, humanized IgG1 monoclonal antibody (mAb) targeting blood dendritic cell antigen 2...
Videos
Rare disease spotlight
@KathyConWom Whether they are vaccinated or not they can still catch and spread the virus. So why are they so desperate to vaccinate everyone ?
@JuliaHB1 The secret to stop this madness is STOP getting tested, you only fuelling numbers and causing restrictions. Feel ok? Live your life. Not feeling ok? Stay home till you get better. Don’t need a test to tell you that you’re sick!
